Drug Trial Radar · NCT02665260
Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum
Last checked: Nov 19, 2026Latest source record: May 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94
Actual
Start
Jul 2012
Primary completion
Nov 2015
Study completion Jan 2016
Sponsor
- Lead sponsor
- Montefiore Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 27, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if cantharidin is a safe and effective treatment for molluscum contagiosum in kids
Conditions
- Molluscum Contagiosum
Interventions
CantharidinDrug
cantharidin 0.7% topical liquid
PlaceboDrug
Placebo topical liquid
Gauze occlusion bandageDevice
Gauze occlusion bandage with adhesive tape
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Who Achieve Complete Clearance at 6 WeeksTime frame: 6 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.